Anavex Life Sciences Stock Analysis

Anavex Stock Analysis Notes

About 32.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.51. Anavex Life Sciences had not issued any dividends in recent years. The entity had 1:4 split on the 7th of October 2015. Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system diseases. The company was incorporated in 2004 and is headquartered in New York, New York. Anavex Lf operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 38 people. For more info on Anavex Life Sciences please contact the company at 844 689 3939 or go to https://www.anavex.com.

Anavex Life Sciences Investment Alerts

Anavex Life Sciences Upcoming and Recent Events

Anavex Largest EPS Surprises

View All Earnings Estimates

Anavex Life Environmental, Social, and Governance (ESG) Scores

Anavex Stock Institutional Investors

Note, although Anavex Life's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Anavex Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 765.7 M.

Anavex Profitablity

Management Efficiency

Anavex Life Sciences has return on total asset (ROA) of (0.2043) % which means that it has lost $0.2043 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3003) %, meaning that it created substantial loss on money invested by shareholders. Anavex Life's management efficiency ratios could be used to measure how well Anavex Life manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.29. Return On Capital Employed is expected to rise to -0.43 this year. At this time, Anavex Life's Total Assets are quite stable compared to the past year. Total Current Assets is expected to rise to about 186.4 M this year, although the value of Other Assets will most likely fall to about 3.7 M.

Technical Drivers

As of the 29th of November, Anavex Life shows the risk adjusted performance of 0.1184, and Mean Deviation of 3.41. Anavex Life Sciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Anavex Life Sciences coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Anavex Life Sciences is priced correctly, providing market reflects its regular price of 9.46 per share. Given that Anavex Life has jensen alpha of 0.4531, we suggest you to validate Anavex Life Sciences's prevailing market performance to make sure the company can sustain itself at a future point.

Anavex Life Sciences Price Movement Analysis

Anavex Life Sciences Insider Trading Activities

Anavex Life Outstanding Bonds

Anavex Life Predictive Daily Indicators

Anavex Life Corporate Filings

Anavex Life Forecast Models

Anavex Life's time-series forecasting models are one of many Anavex Life's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Anavex Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Anavex Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Anavex shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Anavex Life. By using and applying Anavex Stock analysis, traders can create a robust methodology for identifying Anavex entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Anavex analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Anavex analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Anavex Life Sciences stock analysis indicators help investors evaluate how Anavex Life stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Anavex Life shares will generate the highest return on investment. By understating and applying Anavex Life stock analysis, traders can identify Anavex Life position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.